Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03118284 · ClinicalTrials.gov registry record
Foley Catheter Related Bladder Discomfort (FCRBD): Role of Neutrophil Cells
A clinical trial, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- 58
- Enrollment target
NCT03118284 is a clinical trial that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 58 participants.
The verdict
NCT03118284 was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- 58 participants
- Enrollment target
Study Summary
Urinary \[Foley\] catheters \[tubes\] are commonly placed in patients undergoing surgery; approximately 25% of surgical patients will receive one. Among patients who receive urinary catheters, discomfort associated with the Foley catheter is common; between 47-90% of patients experience catheter related bladder discomfort \[CRBD\]. Presence of a foreign object in the bladder even for short periods of time may result in symptoms such as a burning sensation, pain in the lower abdomen, muscle spasms and a sense of urgency to urinate. There is some evidence that suggests that hospital-acquired urinary tract infections are directly related to catheter placement, which causes mechanical damage and local inflammation to the urethra and the bladder. Based on research conducted on a similar mechanism where an airway tube is inserted into a patients throat for delivery of general anesthesia - we hypothesize that CRBD is related to injury and inflammation caused by the catheter placement and that this occurs in a sterile environment.
Interventions
- OTHER Blood collection
- OTHER urine collection
- BEHAVIORAL NRS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2016-11-21 |
| Est. Completion | 2017-08-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03118284
The ClinicalTrials.gov registry entry for NCT03118284 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Blood collection is the first listed.
NCT03118284 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03118284 about?
NCT03118284 is a clinical study titled "Foley Catheter Related Bladder Discomfort (FCRBD): Role of Neutrophil Cells". Urinary \[Foley\] catheters \[tubes\] are commonly placed in patients undergoing surgery; approximately 25% of surgical patients will receive one. Among patients who receive urinary catheters, discomfort associated with the Foley catheter is common; between 47-90% of patients experience catheter rel...
What is the current status of trial NCT03118284?
This trial is currently terminated. The enrollment target is 58 participants. The study started on 2016-11-21. Estimated completion is 2017-08-28.
What interventions are being tested in trial NCT03118284?
The interventions under investigation include: Blood collection (OTHER), urine collection (OTHER), NRS (BEHAVIORAL).
Who is sponsoring clinical trial NCT03118284?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.